GIP is another neuroendocrine hormone that helps regulate blood sugar levels, insulin release, and insulin sensitivity
This varies based on stock availability
The theoretical concerns centre on the potential for these large peptide molecules to affect infant growth, glucose metabolism, or gastrointestinal function, though the extent of oral bioavailability following ingestion in breast milk is uncertain
It simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
But they are important factors for prospective patients to weigh against their individual needs and preferences
Glutamate is the most abundant excitatory transmitter in the central nervous system, utilized at 50- 70% of cortical synapses (1, 2)